These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. On the formation of different types of plasmin by streptokinase activation. MARKUS G; AMBRUS CM J Biol Chem; 1960 Jun; 235():1673-9. PubMed ID: 14421331 [No Abstract] [Full Text] [Related]
43. Fibrinolytic therapy of coronary thrombosis. Controlled trial of 75 cases. DEWAR HA; STEPHENSON P; HORLER AR; CASSELLS-SMITH AJ; ELLIS PA Br Med J; 1963 Apr; 1(5335):915-20. PubMed ID: 14027424 [No Abstract] [Full Text] [Related]
44. Possibilities for therapy with enzymes. SHERRY S Ann Otol Rhinol Laryngol; 1959 Mar; 68(1):34-56. PubMed ID: 13627941 [No Abstract] [Full Text] [Related]
45. Human fibrinolysin with and without urokinase: its effect on experimental arterial thrombi in dogs. ROSCHLAU WH; PAINTER RH Can J Biochem Physiol; 1962 Dec; 40():18-9-38. PubMed ID: 13974768 [No Abstract] [Full Text] [Related]
46. Interaction of streptokinase and plasminogen; demonstration of a reaction product by ultracentrifugation and starch-gel electrophoresis. DE RENZO EC; BARG W; BOGGIANO E; ENGLERT ME; DAVIES MC Biochem Biophys Res Commun; 1963 Jul; 12():105-10. PubMed ID: 14026020 [No Abstract] [Full Text] [Related]
47. RECENT THERAPEUTIC ASPECTS OF THROMBOLYSIS. SCHMUTZLER R Sangre (Barc); 1964; 41():375-6. PubMed ID: 14248821 [No Abstract] [Full Text] [Related]
48. The activation of plasminogen by staphylokinase: comparison with streptokinase. DAVIDSON FM Biochem J; 1960 Jul; 76(1):56-61. PubMed ID: 13814337 [No Abstract] [Full Text] [Related]
49. In vivo activation of the fibrinolytic enzyme system of dogs. TAYLOR FB; SINGLETON J; BICKFORD AF J Appl Physiol; 1963 Mar; 18():334-6. PubMed ID: 13993582 [No Abstract] [Full Text] [Related]
50. An activator system in blood indispensable for formation of plasmin by streptokinase. MULLERTZ S; LASSEN M Proc Soc Exp Biol Med; 1953 Feb; 82(2):264-8. PubMed ID: 13037866 [No Abstract] [Full Text] [Related]
51. [Significance of fibrinolytic enzymes in surgery]. MURAKAMI F Chiryo; 1962 Dec; 44():2155-65. PubMed ID: 13936693 [No Abstract] [Full Text] [Related]
52. PURIFICATION OF STREPTOKINASE AND HUMAN PLASMIN AND THEIR INTERACTION. BLATT WF; SEGAL H; GRAY JL Thromb Diath Haemorrh; 1964 Jul; 11():393-403. PubMed ID: 14191720 [No Abstract] [Full Text] [Related]
53. [HYALINE MEMBRANE SYNDROME AND FIBRINOLYSIS]. OPDECOUL AA; RUBENS A Ned Tijdschr Geneeskd; 1964 Mar; 108():473-5. PubMed ID: 14142099 [No Abstract] [Full Text] [Related]
55. [USE OF PLASMIN IN CRURAL ULCER]. UHRIK J; STEPANEK I Cesk Dermatol; 1964 Jul; 39():261-3. PubMed ID: 14180129 [No Abstract] [Full Text] [Related]
56. [The use of fibrinolysin and varidase in the hyaline membrane syndrome of the premature newborn]. ALVAREZ de los COBOS J; JURADO GARCIA E; DULANTO GUTIERREZ E; VILLAVICENCIO L Rev Esp Pediatr; 1962; 18():567-78. PubMed ID: 14041022 [No Abstract] [Full Text] [Related]
57. ORAL ADMINISTRATION OF A FIBRINOLYSIN IN VASCULAR INFLAMMATION AND OCCLUSION. VARGA LK; MITCHELL JP; MCGAVACK TH Nebr State Med J; 1964 Feb; 49():53-60. PubMed ID: 14117291 [No Abstract] [Full Text] [Related]
58. The streptokinase-plasminogen system. II. Its effect on the development of local streptococcal infections in rabbit skin. KRASNER RI; JANNACH JR J Infect Dis; 1963; 112():134-42. PubMed ID: 14035493 [No Abstract] [Full Text] [Related]
59. [THE CURRENT STATUS OF FIBRINOLYTIC THERAPY]. KAPPERT A Med Klin; 1963 Nov; 58():1844-6. PubMed ID: 14100260 [No Abstract] [Full Text] [Related]
60. [ON THE MECHANISM OF ACTION OF FIBRINOLYTIC SUBSTANCES]. ROSOLLECK H Thromb Diath Haemorrh; 1963 Jul; 143():459-71. PubMed ID: 14081267 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]